Literature DB >> 17551475

Maturity onset diabetes of the young--review.

Galia Gat-Yablonski1, Shlomit Shalitin, Moshe Phillip.   

Abstract

Maturity onset diabetes of the young (MODY) is characterized by a primary defect in insulin secretion and hyperglycemia, nonketotic disease, monogenic autosomal dominant mode of inheritance, age at onset less than 25 years, and lack of auto-antibodies. It accounts for 2-5% of all cases of non-type 1 diabetes. The diagnosis may be made by careful clinical evaluation, but exact subtyping is possible only by genetic analysis. Several genetic factors have been identified as causative agents in MODY, each leading to a different type of the disease. These include the enzyme glucokinase, which causes MODY2, and the transcription factors HNF- 4 alpha, TCF1, I PF-1, TCF2, and NeuroD1, which cause MODY1, 3, 4, 5, and 6, respectively. The genetic findings have important clinical implications, allowing for proper genetic counseling, early diagnosis, and better care of patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17551475

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  13 in total

1.  Vocal characteristics in patients with type 2 diabetes mellitus.

Authors:  Abdul-latif Hamdan; Jad Jabbour; Jihad Nassar; Iyad Dahouk; Sami T Azar
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-05       Impact factor: 2.503

Review 2.  The role of pharmacogenetics in drug disposition and response of oral glucose-lowering drugs.

Authors:  N van Leeuwen; J J Swen; H-J Guchelaar; L M 't Hart
Journal:  Clin Pharmacokinet       Date:  2013-10       Impact factor: 6.447

3.  Molecular genetic testing of patients with monogenic diabetes and hyperinsulinism.

Authors:  James T Bennett; Valeria Vasta; Min Zhang; Jaya Narayanan; Peter Gerrits; Si Houn Hahn
Journal:  Mol Genet Metab       Date:  2014-12-20       Impact factor: 4.797

4.  Relationship between intracerebral hemorrhage and diabetes mellitus: a case-control study.

Authors:  Omid Hesami; Hosein Delavar Kasmaei; Fateme Matini; Farhad Assarzadegan; Behnam Mansouri; Sayena Jabbehdari
Journal:  J Clin Diagn Res       Date:  2015-04-01

5.  The transcription factor Rfx3 regulates beta-cell differentiation, function, and glucokinase expression.

Authors:  Aouatef Ait-Lounis; Claire Bonal; Queralt Seguín-Estévez; Christoph D Schmid; Philipp Bucher; Pedro L Herrera; Bénédicte Durand; Paolo Meda; Walter Reith
Journal:  Diabetes       Date:  2010-04-22       Impact factor: 9.461

Review 6.  Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities.

Authors:  William I Sivitz; Mark A Yorek
Journal:  Antioxid Redox Signal       Date:  2010-04       Impact factor: 8.401

7.  Frequency and characterization of mutations in genes in a large cohort of patients referred to MODY registry.

Authors:  Emily Breidbart; Liyong Deng; Patricia Lanzano; Xiao Fan; Jiancheng Guo; Rudolph L Leibel; Charles A LeDuc; Wendy K Chung
Journal:  J Pediatr Endocrinol Metab       Date:  2021-04-13       Impact factor: 1.634

8.  Efficacy and safety of alogliptin in a pediatric patient with maturity-onset diabetes of the young type 1.

Authors:  Ryosuke Tonouchi; Yusuke Mine; Masako Aoki; Misako Okuno; Junichi Suzuki; Tatsuhiko Urakami
Journal:  Clin Pediatr Endocrinol       Date:  2017-07-27

Review 9.  Dissecting the Brain/Islet Axis in Metabesity.

Authors:  Esther Fuente-Martín; Jose M Mellado-Gil; Nadia Cobo-Vuilleumier; Alejandro Martín-Montalvo; Silvana Y Romero-Zerbo; Irene Diaz Contreras; Abdelkrim Hmadcha; Bernat Soria; Francisco Martin Bermudo; Jose C Reyes; Francisco J Bermúdez-Silva; Petra I Lorenzo; Benoit R Gauthier
Journal:  Genes (Basel)       Date:  2019-05-08       Impact factor: 4.096

10.  Metabolite profiling reveals normal metabolic control in carriers of mutations in the glucokinase gene (MODY2).

Authors:  Peter Spégel; Ella Ekholm; Tiinamaija Tuomi; Leif Groop; Hindrik Mulder; Karin Filipsson
Journal:  Diabetes       Date:  2012-11-08       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.